Accelerating drug development for lung diseases: New insights from single-cell genomics

Drug development for lung diseases is complicated. Most clinical trials that test novel drugs fail due to the fact that laboratory models cannot accurately replicate human physiology.

Leave A Comment

Your email address will not be published. Required fields are marked *